Teresa V. Bowman, PhD

Splicing and Epigenetic Control of Hematopoiesis in MDS and Leukemia

The discovery of new cancer mutations brings the reality of targeted therapy into reach; if we can understand how the mutations work and which other factors are involved. Our research will address these questions and lead to new therapies that will selectively kill mutant cells in patients with myelodysplastic syndromes and leukemia.